1,104 results on '"Humar, Atul"'
Search Results
2. Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020
3. COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients
4. SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain
5. Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion
6. Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave
7. Gravite de la COVID-19 chez les receveurs d'une transplantation d'organe plein au Canada, 2020-2021: etude de cohorte prospective multicentrique
8. Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses
9. Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings
10. Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study
11. Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
12. Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients
13. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
14. Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
15. Successful Deceased Donor Parathyroid Allotransplantation: A Novel Approach in a Patient with Severe Refractory Hypoparathyroidism After Thyroidectomy for Thyroid Cancer.
16. Acyl‐CoA Thioesterase 1 Contributes to Transition of Steatosis to Metabolic‐Associated Steatohepatitis.
17. Prevention and Treatment of CMV Infection (and Other Herpes Viruses)
18. Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study
19. COVID-19: A global transplant perspective on successfully navigating a pandemic
20. Initial lung transplantation experience with uncontrolled donation after cardiac death in North America
21. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial
22. Reply to Hamilton
23. Drug-resistant cytomegalovirus infection after lung transplantation: Incidence, characteristics, and clinical outcomes
24. Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study
25. Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients
26. Humoral response to natural influenza infection in solid organ transplant recipients
27. The basis of liver regeneration: A systems biology approach
28. Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients
29. Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients
30. Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020
31. SAT239 Deceased Donor Parathyroid Allotransplant For Sever Refractory Iatrogenic Hypoparathyroidism
32. A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients
33. A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
34. Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation : A Systematic Review and Meta-analysis
35. Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
36. A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal culture
37. Innate and Adaptive Immune Correlates of Chronic and Self-limiting Epstein-Barr Virus (EBV) DNAemia in Solid-organ Transplant Recipients
38. Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ Transplantation
39. Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
40. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
41. Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy Strategy
42. Risks and Epidemiology of Infections After Pancreas or Kidney–Pancreas Transplantation
43. Infections in Kidney Transplant Recipients
44. T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients
45. Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients
46. Diabetogenic Effects of Immunosuppression: An Integrative Analysis
47. Letermovir as Salvage Therapy for CMV Infection in Transplant Recipients
48. LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions
49. Immunogenicity, Safety, and Breakthrough SARS-CoV-2 infections after COVID-19 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
50. Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.